Overweight Clinical Trial
Official title:
The Effect of Activity on Insulin Sensitivity and Lipid Metabolism in Sedentary, Overweight People.
The effect of Non-Exercise Activity Thermogenesis (NEAT) or inactivity on insulin
sensitivity and lipid metabolism is unclear. Research recently published shows that
activities associated with everyday activities, summarized as NEAT, such as walking and
standing, have a much greater role in energy expenditure than exercise. Therefore, the
objective of the present study is to evaluate the effect of 4 days of inactivity (mainly
sitting), 4 days of everyday activities (sitting, walking and standing), and 4 days of
inactivity and exercise (sitting and biking) on glucose metabolism and insulin sensitivity
using an oral glucose tolerance test, and on lipid metabolism in sedentary, overweight
people. The investigators hypothesize that:
1. 4 days of everyday activities (NEAT) will cause an increased glucose tolerance and
increased insulin sensitivity compared to 4 days of inactivity in sedentary, overweight
people.
2. 4 days of exercise will improve glucose tolerance and insulin sensitivity more than 4
days of NEAT with equal energy expenditure, in sedentary, overweight people.
3. Fasting triglyceride will have the same course as glucose, mentioned in 1. and 2.
To evaluate the effect of Non-Exercise Activity Thermogenesis (NEAT) on glucose and lipid
metabolism in sedentary, overweight people, the subjects included in the study protocol will
follow 3 times a certain activity program of 4 days. These activity programs are:
- Inactivity: 14 hours of sitting, 2 hours of everyday activities, 8 hours of sleeping or
laying down per day.
- NEAT: 4 hours of walking, 8 hours of sitting, 2 hours of standing, 2 hours of everyday
activities, 8 hours of sleeping or laying down per day.
- Exercise: 1 hour biking, 13 hours of sitting, 2 hours of everyday activities, 8 hours
of sleeping or laying down per day.
The subjects will be biking using a home trainer, measuring energy expenditure, and
supervised by one of the members of the research team. They will bike until they have
reached a certain amount of kCal. The subjects will wear two accelerometers during all 3
activity programs to evaluate the amount of each activity (sitting, walking, standing,
laying/sleeping). The Computer Science and Applications (CSA) Actigraph accelerometer will
be placed on the back and the Continuous Activity Monitor (CAM) Maastricht instrument on the
leg. Furthermore, the subjects will be requested to note their activities and dietary intake
in a diary. After every 4 days of each activity program, an oral glucose tolerance test will
be performed in the morning (fasting state) of the next day (day 5). Before and 15, 30, 45,
60, 90, 120 minutes after ingestion of 75 gram of glucose in water, blood will be drawn for
measurements of glucose and insulin. Only at baseline (t=0 minutes), blood will be drawn to
measure cholesterol, HDL, LDL, triglycerides, apoA and apoB.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
| Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |